medicine (Photo credit: taiyofj)
Judging by some of the heavy action in the world of biotechnology, one could easily conclude that the industry is going to the dogs. Or cats, maybe.
There are start-ups named Nexvet and VetDC, CanFel Therapeutics (as in canine and feline), and even Fetch Pharma.
It’s a new example of pack behavior: Entrepreneurs with pedigrees from companies like Genentech and Amgen are now turning their attention to pets. They hope to develop innovative drugs for dogs and cats like those that have revolutionized the treatment of diseases like cancer and arthritis in people.
“We’ve been drugging ourselves for a long time and more recently we’ve been drugging our kids,” said Oleg Nodelman, an investor in and director of Kindred Biosciences, one of the new companies. “Why shouldn’t our pets have access to medicine?”
They do already, of course. Many of the big pharmaceutical companies have long had veterinary drug divisions. Eli Lilly’s animal division, Elanco, for instance, sells the company’s Prozac antidepressant under the name Reconcile to treat canine separation anxiety.
But the new entrepreneurs say they will be more nimble and do what the big companies are not doing, just as the early human medicine biotech companies did.
The big companies focus more on livestock — edible animals as opposed to petable ones, said Steven St. Peter, chief executive of Aratana Therapeutics, a pet biotech company. Their offerings for pets are mainly vaccines and treatments for fleas, ticks and worms.
The new companies hope instead to treat diseases like cancer and arthritis. Many are trying to develop monoclonal antibodies, which are proteins made in living cells. Such antibodies, like Humira for rheumatoid arthritis and Herceptin for breast cancer, are huge sellers in human medicine but have had almost no role so far in animal health.
Read more . . .
The Latest on: Biotech Drugs for Pets
via Google News
The Latest on: Biotech Drugs for Pets
- Stem Cell Technology: The Only Constant Is Changeon December 2, 2019 at 4:45 am
For example, dog owners may be attracted to an animal biotech company called Gallant, which recently launched a stem cell ... And exploiting these connections could help researchers establish new uses ...
- Amarin Stock’s Big Q4 Gains May Not Last as Big Dogs are Barkingon November 25, 2019 at 2:16 am
All of the enthusiasm centers on the pharmaceutical’s sole marketed drug, Vascepa. What is Vascepa ... considering the underlying company’s dependence on Vascepa. Compare Brokers Plus, the big dogs ...
- Animal Health Active Pharmaceutical Ingredients Market 2019 Global Industry Analysis, Leading Players and Supply Demand Report 2025on November 18, 2019 at 10:50 am
However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries are restricting the market growth. The global Animal Health Active ...
- Biotech firms eye big profits as owners seek cures for their sick petson September 22, 2019 at 11:11 am
In recent years, the cost of genetic testing and biotech drug production has fallen sharply, making biotechnology for pets financially viable at much lower prices, industry experts said. Sector leader ...
- Biotech is going to the dogs - and big profits awaiton September 19, 2019 at 11:56 am
In recent years, the cost of genetic testing and biotech drug production has fallen sharply, making biotechnology for pets financially viable at much lower prices, industry experts said. For a FACTBOX ...
- Biotech is going to the dogs - and big profits awaiton September 19, 2019 at 4:08 am
In recent years, the cost of genetic testing and biotech drug production has fallen sharply, making biotechnology for pets financially viable at much lower prices, industry experts said. Sector leader ...
- Biotech is going to the dogs - and big profits awaiton September 19, 2019 at 3:21 am
In recent years, the cost of genetic testing and biotech drug production has fallen sharply, making biotechnology for pets financially viable at much lower prices, industry experts said. For a FACTBOX ...
- Positron Emission Tomography (PET): Questions and Answers about CGMP Regulations for PET Drugson September 1, 2019 at 5:09 pm
1. What did FDA do today? The Food and Drug Administration (FDA) issued regulations establishing the Current Good Manufacturing Practices (CGMP) for positron emission tomography (PET) drugs. The ...
- Rochester biotech startup targeting cancer in dogson August 30, 2019 at 5:10 am
Helping man's best friend could also help mankind. That's the idea at the core of Life Engine Animal Health or LEAH Labs, an early-stage gene editing start-up in Rochester that is working on a cancer ...
- Pet Dogs Help Biotech Startups Find New Weapons to Fight Canceron July 24, 2019 at 5:00 pm
A few weeks back, a black-and-white terrier mix named Chance entered a clinical trial for a drug that ... schools and pharmaceutical companies. Genelux, which was founded in 2001, is one of several ...
via Bing News
